Skip to main content
2025 DC/CSEM Professional Conference Main banner

Akshay Jain, MD, FRCPC, FACE, ECNU, DABIM, DABOM

Endocrinologist
UNIVERSITY OF BRITISH COLUMBIA
University of British Columbia
Surrey, British Columbia, Canada

Dr. Akshay Jain is the first Canadian physician to be triple board-certified by the
American Boards in Endocrinology, Internal Medicine and Obesity Medicine.
He trained in Internal Medicine at Rochester, NY where he became the only 4-
time winner of the prestigious Rochester Academy of Medicine Awards. He
completed his Fellowship in Endocrinology at Harbor UCLA/City of Hope in Los
Angeles, CA.
He is the only non-American physician to win the AACE Rising Star in
Endocrinology Award (2022) and to feature on Medscape’s list of 25 Top Rising
Stars of Medicine (2020). He is the first North American to win the prestigious
Etzwiler Diabetes Scholarship at the International Diabetes Center and Mayo
Clinic.
He is a renowned educator and has spoken at over 1000 medical
conferences/events across the world till date.He is a co-author of the 2025 Obesity Canada Guidelines chapter on Pharmacotherapy and
the 2023 Diabetes Canada Guidelines chapter on Mental Health and Diabetes. His
novel approach to patient care using a multidisciplinary team won him the
Healthcare Innovator Award by Fraser Health, a first for any endocrinologist.
He has active YouTube/Instagram channels dedicated to patient education with
hundreds of thousands of views till date.

He is fluent in 6 languages. He is the winner of the Top 25 Canadian Immigrant Award, the
Healthcare Innovator Award by Fraser Health, the Healthcare Achievement
Award by Drishti Magazine and was also featured on The Peak’s list of Emerging
Leaders of Canada.

Disclosure(s): Abbott: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Speaker/Honoraria (Ongoing); Amgen: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Astra Zeneca: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Bausch Healthcare: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); CPD network: Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Speaker/Honoraria (Ongoing); Eisai: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); gsk: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); MDBriefcase: Speaker/Honoraria (Ongoing); medtronic: Speaker/Honoraria (Ongoing); Moderna: Speaker/Honoraria (Ongoing); Novo Nordisk: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Partners in Progressive Medical Education: Consultant (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); PocketPills: Advisory Board (Ongoing); roche: Advisory Board (Ongoing); Sandoz: Advisory Board (Ongoing); sanofi aventis: Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Takeda: Advisory Board (Ongoing); Timed Right: Speaker/Honoraria (Ongoing); ypsomed: Advisory Board (Ongoing)

Presentation(s):